NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Real-world Insight Into Systemic Therapies for HCC: Single-center Study

RecruitingN/A

Sponsor: Mansoura University

Conditions: HCC - Hepatocellular Carcinoma

Countries: Egypt

Real-world data from a single-center experience evaluating patients with hepatocellular carcinoma (HCC) receiving systemic therapies

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* patient with HCC
* Child-Pugh class A, B7
* Performance state 0-1 (Eastern Cooperative Oncology Group (ECOG scale).
* Barcelona Clinic Liver Cancer (BCLC) stage C or BCLC stage B with diffuse, infiltrative or extensive bilobar involvement or BCLC stage B with tumor progression after TACE.

Exclusion Criteria:

* patient with other tumor than HCC
* Child-Turcotte-Pugh score B (8,9) and C.
* Patients eligible for treatment other than systemic therapy according to Barcelona Clinic liver cancer.

Locations (1)

Al Mansurah, Dakahlia Governorate, Egypt